Skip to main content

Ocular Hypertension clinical trials at UCSF

2 research studies open to eligible people

Ocular hypertension occurs when the pressure in the eye is above normal levels. UCSF is conducting a study to see if using less energy in laser treatments is just as effective. Another study is examining whether smaller eye drops can better control eye pressure.

Showing trials for
  • Clarifying the Optimal Application of SLT Therapy Trial

    open to eligible people ages 18 years and up

    The goal of this study is to understand if SLT performed at low energy is as effective as SLT performed at standard energy, and also to see if repeating SLT at low energy once a year will prevent or delay the need for daily eye drop medications better than waiting for SLT to wear off before repeating it.

    San Francisco, California and other locations

  • Nanodropper Device on Intraocular Pressure in Patients With Glaucoma

    open to eligible people ages 18 years and up

    Glaucoma is the leading cause of irreversible blindness worldwide. Previous studies demonstrate that smaller eye drops used in the treatment of glaucoma are just as efficacious as their larger counterparts. The proposed study hopes to demonstrate the non-inferiority of using Nanodropper to lower intraoccular pressure (IOP) in glaucoma patients compared to standard of care eye drops.

    San Francisco, California

Last updated: